MXVIX | VTSAX | MXVIX / VTSAX | |
Total Expense Ratio | 0.49 | 0.04 | 1,225% |
Annual Report Gross Expense Ratio | 0.49 | 0.04 | 1,225% |
Fund Existence | 22 years | 25 years | - |
Gain YTD | 15.187 | 14.222 | 107% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.64B | 2.02T | 0% |
Annual Yield % from dividends | 0.41 | 1.13 | 37% |
Returns for 1 year | 17.02 | 16.58 | 103% |
Returns for 3 years | 81.92 | 84.43 | 97% |
Returns for 5 years | 72.96 | 87.23 | 84% |
Returns for 10 years | 162.93 | 233.64 | 70% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PIUIX | 26.64 | N/A | N/A |
Federated Hermes International Equity IS | |||
JFNCX | 62.53 | N/A | N/A |
Janus Henderson Global Life Sciences C | |||
JOEIX | 15.02 | N/A | N/A |
JOHCM Emerging Markets Opps Advisor | |||
BHCHX | 19.58 | N/A | N/A |
Baron Health Care Instl | |||
RLBBX | 38.01 | -0.61 | -1.58% |
American Funds American Balanced R2 |